This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies. Click here for more information on cookies and to set your preferences.

Continue
Integrity in managing company information

To protect and preserve our competitiveness, image & reputation

Protecting confidential  and sensitive information
Protecting confidential and sensitive information
At Sanofi protecting any confidential and sensitive information is essential.
Protecting confidential  and sensitive information

Confidential information is one of our most valuable assets. At Sanofi protecting any confidential and sensitive information is essential. This commitment applies equally to information about our Company, our employees, and our business partners.

Inappropriate use or disclosure of such information can cause serious harm to our company, business partners, suppliers and customers, weakening our competitiveness, exposing us to liability, and damaging our reputation.

“Confidential information” means any information, whatever its form, that is not in the public domain, and that we must protect from any inappropriate use or disclosure, because such use or disclosure could potentially harm the Company.

Examples of confidential information include:

  • the company’s business and financial condition
  • strategic/business plans
  • pricing information
  • marketing plans and business development strategies
  • clinical data, research and technical data, inventions, and innovations
  • confidential information entrusted by business partners.